Recruitment of racial and ethnic minorities to clinical trials conducted within specialty clinics: an intervention mapping approach

Abstract

BackgroundDespite efforts to increase diversity in clinical trials, racial/ethnic minority groups generally remain underrepresented, limiting researchers’ ability to test the efficacy and safety of new interventions across diverse populations. We describe the use of a systematic framework, intervention mapping (IM), to develop an intervention to modify recruitment behaviors of coordinators and specialist investigators with the goal of increasing diversity in trials conducted within specialty clinics. To our knowledge IM has not been used in this setting.MethodsThe IM framework was used to ensure that the intervention components were guided by health behavior theories and the evidence. The IM steps consisted of (1) conducting a needs assessment, (2) identification of determinants and objectives, (3) selection of theory-informed methods and practical applications, (4) development and creation of program components, (5) development of an adoption and implementation plan, and (6) creation of an evaluation plan.ResultsThe intervention included five educational modules, one in-person and four web-based, plus technical assistance calls to coordinators. Modules addressed the intervention rationale, development of clinic-specific plans to obtain minority-serving physician referrals, physician-centered and patient-centered communication, and patient navigation. The evaluation, a randomized trial, was recently completed in 50 specialty clinics and is under analysis.ConclusionsUsing IM we developed a recruitment intervention that focused on building relationships with minority-serving physicians to encourage minority patient referrals. IM enhanced our understanding of factors that may influence minority recruitment and helped us integrate strategies from multiple disciplines that were relevant for our audience.

A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach

“…This problem is further complicated by the fact that racial and ethnic minority groups generally remain underrepresented in clinical trials (62), limiting the capability to test the efficacy and safety of new clinical interventions across diverse populations and leading to a lack of T-cell data for ethnicities in which viral epidemic currently spreads (15). Therefore, a vaccine that delivers good results for certain groups in Phase I and II trials does not necessarily guarantee strong protective responses in ethnic minority populations that are in more urgent need of new vaccine initiatives (63). Genetic variability of the HLA system may affect susceptibility and severity of the disease caused by SARS-CoV-2, as recently discussed in a comprehensive in silico analysis of viral peptide-HLA class I binding affinity across 145 HLA types (23).…”

Disparities in Cardiovascular Care and Outcomes for Women From Racial/Ethnic Minority Backgrounds

“…Data to guide trial enrollment to ensure recruitment of diverse populations is emerging [127][128][129][130], yet limited. One clear recommendation to improve diverse enrollment involves advocating for gender and racial/ethnic diversity among the physician workforce.…”

Perspective: Design and Conduct of Human Nutrition Randomized Controlled Trials

“…Multisite studies or other strategies should be considered. If the specific aims of the protocol requires a certain race or ethnicity, that information is often based on self-report ( 34 , 35 ). Given the interest in understanding health disparities, especially with nutrition-related health outcomes, it is important to appreciate the complexities of self-reported information about race or ethnicity and allow for multiple responses.…”